Feedback / Questions
Tremfya (guselkumab) - J&J
Tremfya: Data from P2/3 GALAXI trial (NCT03466411) for Crohn's disease in 2020
(J&J)
-
Jul 16, 2020 -
Key 2020 Events
P2/3 data
•
Crohn's disease • Inflammatory Bowel Disease
http://www.investor.jnj.com/_document/key-events-q2-2020?id=00000173-574f-d152-a3fb-5fff4bfb0000
Jul 16, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious